Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin O Leach

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2017
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRIRafal Panek, Liam Welsh, Lauren C J Baker, et al.
Academic Radiology|August 13, 2013
Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphomaFernando Arias-Mendoza, Geoffrey S Payne, Kristen Zakian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2014
Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkersTimothy A Yap, Li Yan, Amita Patnaik, et al.
NMR in Biomedicine|March 25, 2015
Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brainMatthew Grech-Sollars, Patrick W Hales, Keiko Miyazaki, et al.
NMR in Biomedicine|February 2, 2024
Characterisation of paediatric brain tumours by their MRS metabolite profilesSimrandip K Gill, Heather E L Rose, Martin Wilson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 30, 2012
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combinedEveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, et al.
Familial Cancer|January 17, 2017
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Emma Killick, Sarah Thomas, et al.
Journal of Medical Genetics|November 14, 2019
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic <i>TP53</i> mutation carriers: a case-controlled study (SIGNIFY)Elizabeth K Bancroft, Sibel Saya, Emma Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Rebekah Weston, Cormac Owens, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Journal of Neuro-Oncology|May 16, 2016
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine gliomaFernando Carceller, Lucy A Fowkes, Komel Khabra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2017
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRIRafal Panek, Liam Welsh, Lauren C J Baker, et al.
Academic Radiology|August 13, 2013
Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphomaFernando Arias-Mendoza, Geoffrey S Payne, Kristen Zakian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2014
Interrogating two schedules of the AKT inhibitor MK-2206 in patients with advanced solid tumors incorporating novel pharmacodynamic and functional imaging biomarkersTimothy A Yap, Li Yan, Amita Patnaik, et al.
NMR in Biomedicine|March 25, 2015
Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brainMatthew Grech-Sollars, Patrick W Hales, Keiko Miyazaki, et al.
NMR in Biomedicine|February 2, 2024
Characterisation of paediatric brain tumours by their MRS metabolite profilesSimrandip K Gill, Heather E L Rose, Martin Wilson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 30, 2012
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combinedEveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, et al.
Familial Cancer|January 17, 2017
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Emma Killick, Sarah Thomas, et al.
Journal of Medical Genetics|November 14, 2019
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic <i>TP53</i> mutation carriers: a case-controlled study (SIGNIFY)Elizabeth K Bancroft, Sibel Saya, Emma Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Rebekah Weston, Cormac Owens, et al.
Pageof 19